Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injection for intravenous use. It treats serious Gram‑positive bacterial infections, including MRSA and VRE, in hospitalized patients.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Linezolid is indicated for infections caused by Gram‑positive bacteria and is used in hospital settings for serious resistant infections.

- Complicated skin and soft tissue infections: provides bacterial eradication and clinical cure. - Hospital‑acquired or ventilator‑associated pneumonia: improves respiratory outcomes and reduces mortality. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: achieves rapid bacterial clearance. - Vancomycin‑resistant Enterococcus (VRE) infections: offers an effective alternative when other agents fail.

Linezolid may cause a range of adverse reactions that clinicians monitor during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Thrombocytopenia: reduced platelet count, usually reversible.

Serious or Rare Side Effects: - Myelosuppression: severe anemia or neutropenia requiring hematologic evaluation. - Peripheral neuropathy: sensory changes that may become irreversible. - Serotonin syndrome: risk when combined with serotonergic agents, presenting with agitation, hyperreflexia, and fever.

Before initiating Linezolid, clinicians should assess patient history and laboratory parameters.

- Renal impairment: adjust monitoring as drug is partially excreted renally. - Hepatic dysfunction: evaluate liver enzymes regularly. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Prolonged therapy (>14 days): monitor blood counts for myelosuppression. - Hypersensitivity: discontinue if rash or anaphylaxis occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Rifampicin: may reduce linezolid plasma concentrations. - Warfarin: potential for increased anticoagulant effect; monitor INR. - Ethanol: may enhance central nervous system depression; advise caution.